EP
AMED

Essential Partners’s Amedisys AMED Stock Holding History

Essential Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26
Closed -$2.56K – 2674
2025
Q2 		$2.56K Buy
+26
New +$2.46K ﹤0.01% 1248

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $136M AUM 59.34% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Essential Partners's AMED Position: Q3 2025 in Review

Essential Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 26 shares — an estimated $2.56K sold.

Essential Partners first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $2.56K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Essential Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Essential Partners sold 26 Amedisys shares in Q3 2025, an estimated $2.56K.
  • Essential Partners first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Essential Partners's Amedisys position peaked at $2.56K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Essential Partners's 13F filing for Q3 2025, filed 21 May 2026.